
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
April 10, 2025
Host Jonathan Miller interviews CEO:John Lai. He describes how PetVivo provides the best standards for Pets in medicine.